Phosphodiesterase 9a as prostate cancer marker

Phosphodiesterase 9a as prostate cancer marker

  • CN 102,459,645 A
  • Filed: 05/11/2010
  • Published: 05/16/2012
  • Est. Priority Date: 05/12/2009
  • Status: Active Application
First Claim
Patent Images

1. be used for phosphodiesterase 9A (PDE9A) as the mark use that is used for prostate cancer.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×